Compounds > diaziquone

Page last updated: 2024-08-23

diaziquone and Thrombopenia

diaziquone has been researched along with Thrombopenia in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	7 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bedikian, AY; Bodey, GP; Karlin, DA; Korinek, J; Stroehlein, JR	1
Moertel, CG; O'Connell, MJ; Rubin, J; Schutt, AJ; van Hazel, GA	1
Al-Sarraf, M; Ensley, J; Kish, J; Tapazoglou, E	1
Cascino, TL; Dinapoli, RP; Eagan, RT; O'Fallon, JR; O'Neill, BP; Scheithauer, B	1
Al-Sarraf, M; Decker, DA; Goldfarb, S; Kish, J	1
Anderson, K; McIntyre, OR; Vinciguerra, V	1
Baker, LH; Fletcher, WS; McCracken, JD; O'Bryan, RM; Shildt, R; Stephens, RL; Subramanian, VP	1

Trials

1 trial(s) available for diaziquone and Thrombopenia

Article	Year
Diaziquone for resistant multiple myeloma. Cancer and Leukemia Group B. Cancer treatment reports, 1985, Volume: 69, Issue:3 Topics: Adult; Aged; Aziridines; Azirines; Benzoquinones; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Multiple Myeloma; Pilot Projects; Thrombocytopenia	1985

Other Studies

6 other study(ies) available for diaziquone and Thrombopenia

Article	Year
Phase II clinical evaluation of AZQ in colorectal cancer. American journal of clinical oncology, 1982, Volume: 5, Issue:5 Topics: Adult; Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Colonic Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Middle Aged; Neutropenia; Rectal Neoplasms; Thrombocytopenia	1982
A phase II study of aziridinylbenzoquinone (AZQ) in advanced large bowel carcinoma. American journal of clinical oncology, 1982, Volume: 5, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Colonic Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukopenia; Male; Middle Aged; Rectal Neoplasms; Thrombocytopenia	1982
Response rate and toxicity with aziridinylbenzoquinone in patients with recurrent gliomas. A progress report. American journal of clinical oncology, 1988, Volume: 11, Issue:4 Topics: Adolescent; Adult; Aged; Anemia; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Drug Evaluation; Female; Glioma; Humans; Leukopenia; Male; Middle Aged; Neoplasm Recurrence, Local; Thrombocytopenia; Vomiting	1988
Comprehensive phase II evaluation of aziridinylbenzoquinone (AZQ, diaziquone) in recurrent human primary brain tumors. Journal of neuro-oncology, 1987, Volume: 5, Issue:4 Topics: Adolescent; Adult; Aziridines; Azirines; Benzoquinones; Brain Neoplasms; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasm Recurrence, Local; Thrombocytopenia	1987
Phase II clinical evaluation of AZQ in renal cell carcinoma. American journal of clinical oncology, 1986, Volume: 9, Issue:2 Topics: Adenocarcinoma; Adult; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Drug Evaluation; Female; Humans; Kidney Neoplasms; Leukopenia; Male; Thrombocytopenia	1986
Phase II trial of diaziquone in advanced large bowel carcinoma in previously treated and untreated patients: a Southwest Oncology Group Study. Cancer treatment reports, 1985, Volume: 69, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Colonic Neoplasms; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Thrombocytopenia	1985